Huang Lilan, Yu He, Fang Ying
Medical School of the Ministry of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Department of Endocrinology, CR & WISCO General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Front Cardiovasc Med. 2024 Jan 31;11:1332754. doi: 10.3389/fcvm.2024.1332754. eCollection 2024.
The common adverse reactions of liraglutide are hypoglycemia and gastrointestinal reactions. This case reports a patient with type 2 diabetes mellitus who had an increase in ventricular premature beats after using liraglutide and a decrease in ventricular premature beats after stopping liraglutide, suggesting that clinicians should rule out the possibility of drug-related adverse reactions when using liraglutide in the treatment of diabetes mellitus complicated with coronary heart disease and arrhythmia.
利拉鲁肽的常见不良反应为低血糖和胃肠道反应。本病例报告了1例2型糖尿病患者,使用利拉鲁肽后室性早搏增多,停用利拉鲁肽后室性早搏减少,提示临床医生在使用利拉鲁肽治疗合并冠心病和心律失常的糖尿病时应排除药物相关不良反应的可能性。